CACLP - The largest IVD Expo & Conference

2022 Chinese IVD Companies Q1 Released —— Autobio, BSBE, Easy Diagnosis, Medicalsystem, Dian Diagnostics, Hybribio, Kingmed

Industry news | 27 April, 2022 | CACLP


Autobio Diagnostics CO.,Ltd. (603658.SH)

CACLP Booth NO. A4-1309

 

On April 27, Autobio released its annual report for the first quarter of 2022. In the first quarter, the total operating income was CNY 1.03 billion, a year-on-year increase of 26.2%; the net profit attributable to the parent was CNY 240 million, a year-on-year increase of 40.1%; earnings per share were CNY 0.41 yuan.

 

Beijing Strong Biotechnologies,Inc. (300406.SZ)

CACLP Booth NO. A4-0101

 

On April 27, BSBE released its annual report for the first quarter of 2022. In the first quarter, the total operating income was CNY 3.73 billion, a year-on-year decrease of 0.29%; the net profit attributable to the parent was CNY 98.1103 million, a year-on-year decrease of 12.53%; earnings per share were CNY 0.17 yuan.

 

Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (002932.SZ)

CACLP Booth NO. A4-1314

 

On April 27, Easy Diagnosis released its annual report for the first quarter of 2022.In the first quarter, the total operating income was CNY 2.49 billion, a year-on-year increase of 267.4%; the net profit attributable to the parent was CNY 1.39 billion, a year-on-year increase of 307.1%; earnings per share were CNY 13.51.

 

Medicalsystem Biotechnology Co.,Ltd. (300439.SZ)

CACLP Booth NO. A5-1309

 

On April 27, Medicalsystem released its annual report for the first quarter of 2022. In the first quarter, the total operating income was CNY 580 million, an increase of 8.7% year-on-year; the net profit attributable to the parent was CNY 69.561 million, a year-on-year decrease of 7.9%, and earnings per share were CNY 0.18.

 

Dian Diagnostics Group CO.,LTD. (300244.SZ)

CACLP Booth NO. A3-1709

 

On April 27, Dian Diagnostics released its annual report for the first quarter of 2022. In the first quarter, the total operating income was CNY 4.65 billion, a year-on-year increase of 62.1%; the net profit attributable to the parent was CNY 750 million, a year-on-year increase of 122.6%; earnings per share were CNY1.21.

 

Guangdong Hybribio Biotech Co.,Ltd. (300639.SZ)

CACLP Booth NO. A1-2609

 

On April 27, Hybribio released its annual report for the first quarter of 2022. In the first quarter, the total operating income was CNY 1.51 billion, a year-on-year increase of 147.9%; the net profit attributable to the parent was CNY 500 million, a year-on-year increase of 190.6%; earnings per share were CNY 1.72.

 


Guangzhou Kingmed Diagnostics Group Co.,Ltd. (603882.SH)

 

On April 27, Kingmed released its annual report for the first quarter of 2022. In the first quarter, the total operating income was CNY 4.25 billion, a year-on-year increase of 58.7%; the net profit attributable to the parent was CNY 850 million, a year-on-year increase of 58%; earnings per share were CNY1.83.

Filed under:
Press contact CACLP - The largest IVD Expo & Conference

Stay in touch with CACLP News

We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News, sign-up for our newsletter today.

  • Name *
  • Email *
  • Company name *
  • Country *
    CACLP - The largest IVD Expo & Conference

By subscribing our newsletter, you agree to our Privacy Policy. You can unsubscribe at anytime.

Share
Opening Countdown
0 0 0

Day(s)

0 0

Hour(s)

0 0

Min(s)

Room 2201-2203 & 2205, Cloud Nine Plaza
1118 West Yan’an Road
Shanghai, China
200052

Copyright © 2024 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )

We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy & Cookies for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

CACLP - The largest IVD Expo & Conference